Dallas-based Trinity Hunt Partners announced a majority investment in Centricity Research, a clinical research services provider specializing in conducting Phase I-IV clinical trials across more than 40 therapeutic areas.
The amount of the investment was not disclosed.
“We are confident that Trinity Hunt’s expertise in partnering with growing healthcare services companies and its shared commitment to providing an empowering team environment will help us drive innovation and make significant strides as we continue to expand,” Centricity President Dr. Jeff Kingsley said in a statement.
Based in Columbus, Georgia, Centricity has more than 35 locations across the United States and Canada and has the capabilities and expertise in a vast array of trial types to partner effectively with pharmaceutical sponsors and contract research organizations (CROs) in the design and execution of clinical trials, the company said.
Expanding ‘a market leader in the clinical research space’
Its centralized processes, expansive patient recruitment capabilities, integrated technology, and team of clinical research professionals have successfully led to more than 2,500 studies conducted and more than 100 FDA and Health Canada drug approvals.
Trinity Hunt, a growth-oriented private equity firm focused on services businesses, said that in partnership with Centricity’s management team, it plans to expand Centricity’s capabilities and therapeutic coverage areas by investing in organic growth initiatives and acquiring complementary clinical research site businesses.
Trinity Hunt and Centricity said that they are aligned in their focus on preserving and enhancing the existing culture and talent of the company.
“The clinical research industry is highly fragmented, and clinical trials are becoming increasingly complex for sponsors and CROs to execute. Trinity Hunt recognizes the opportunity these market dynamics present for the growth of a leading organization like Centricity, and we are committed to collaborating with its outstanding team across North America to continue to scale the business as a market leader in the clinical research space,” Trinity Hunt Principal John Oakes said in a statement.
In March, Trinity Hunt Partners announced another majority investment: digital marketing life sciences agency Supreme Optimization.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Dallas-based growth-oriented private equity firm Trinity Hunt Partners announced a majority investment in Supreme Optimization, a digital marketing agency focused exclusively on life sciences. No financial details were released. Founded in 2015 and based in Southern California with a team distributed across the U.S., Canada, and UK, Supreme has grown rapidly to become a thought leader in the life sciences marketing space, combining top digital marketing strategies with deep scientific expertise to deliver exceptional results for clients, Trinity Hunt Partners said. Supreme’s founder and CEO Sheldon Zhai, along with other members of management, will remain significant shareholders and continue to…
-
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative. UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
-
The initial investment will support the commercialization of life science research, including identifying researchers with entrepreneurial mindsets, safeguarding intellectual property, and recruiting key executives.
-
The Cancer Prevention & Research Institute of Texas has provided more than $3.1 billion in funding toward the development of cancer-fighting therapeutics, devices, diagnostics, and tools since 2010. It's now issued a call for startups and early-stage companies to apply for product development research grants for the 2023 fiscal year. “CPRIT’s mission is to invest in the research prowess of Texas institutions while expediting breakthroughs in cancer cures and prevention,” CEO Wayne Roberts said last May.
-
"We don’t have years to wait—it’s important that the data and recommendations are delivered as quickly as possible, in ways people can understand and apply," says Dr. Scott Walters, who served as steering committee chair of the 67-community HEALing Communities Study. A center at the University of North Texas Health Science Center will share findings to communities most affected by the worsening opioid crisis. “We already know quite a bit about best practices,” Walters notes.
